ByHeart Formula Recall Alert — Infant Botulism Cases Reported Nationwide

What Sparked the ByHeart Formula Recall?

ByHeart Formula Recall alert: FDA warns parents after botulism cases nationwide. Check affected lots and learn how to keep infants safe.

What Sparked the ByHeart Formula Recall?

In early November 2025, an alarming wave of infant illnesses across ten U.S. states sent shockwaves through the parenting community. Thirteen infants were hospitalized after developing symptoms consistent with infant botulism, a rare but serious illness caused by a toxin produced by Clostridium botulinum bacteria.

Following the reports, ByHeart Inc., a New York–based manufacturer of organic infant formulas, voluntarily initiated a recall of two lots of its Whole Nutrition Infant Formula. The recall, announced in cooperation with the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), immediately drew nationwide attention.

The affected batches were identified as 206VABP/251261P2 and 206VABP/251131P2, both with “Use By” dates of December 1, 2026. Parents and caregivers were urged to discontinue use and safely dispose of any remaining cans.

This incident marks one of the most serious formula-related public health scares since 2022, when widespread recalls disrupted the infant nutrition supply chain. For many families who trusted ByHeart for its clean-label commitment and transparency, the news was shocking and heartbreaking.

Understanding Infant Botulism and Its Risks

Infant botulism occurs when spores of C. botulinum germinate in a baby’s intestines and produce toxins that interfere with muscle control. Unlike foodborne botulism in adults, infant cases often originate from environmental exposure or contaminated food sources.

Symptoms typically appear between 3 and 30 days after exposure and may include:

Constipation or reduced bowel movements
Weak cry or poor feeding
Floppiness or loss of head control
Drooping eyelids
General lethargy or paralysis in severe cases

Because infants under twelve months have immature gut microbiota, they are particularly vulnerable. Even small amounts of contamination can trigger severe illness. Prompt medical attention and antitoxin treatment are crucial; with proper care, most infants recover fully, though hospitalization may last several weeks.

In this outbreak, the CDC confirmed that toxin traces were consistent with ingestion of contaminated formula, raising deep concern about production-line sanitation and ingredient safety protocols.

FDA and CDC Findings Behind the Recall

Both the FDA and CDC launched a joint investigation in late October 2025 after pediatricians in multiple states began reporting similar cases of infant paralysis. Samples collected from affected households and opened formula cans were analyzed in federal labs.

Preliminary findings indicated that C. botulinum spores were present in two specific lots produced at ByHeart’s Pennsylvania facility. According to the FDA’s public report, the contamination may have originated from a dry-mixing silo, where incomplete sterilization allowed bacterial spores to survive.

On November 7, 2025, the FDA formally notified ByHeart, prompting the company to recall the identified lots voluntarily. In a statement, ByHeart emphasized that no other production batches or products—including its ready-to-feed and gentle-blend formulas—were affected.

The agency also announced expanded inspections across multiple formula plants nationwide, reinforcing its post-2022 mandate for stricter environmental-testing requirements.

Which ByHeart Formula Lots Are Affected?

Parents are urged to check the batch code printed on the bottom of their formula can. The two recalled lots are:

Batch Code 206VABP/251261P2 — Use By 01 Dec 2026
Batch Code 206VABP/251131P2 — Use By 01 Dec 2026

If your product matches either code, do not feed it to your baby. Instead:

Dispose of the formula safely in a sealed plastic bag.
Wash your hands thoroughly after handling.
Contact ByHeart’s customer-support line or visit byheart.com/recall for refund instructions.
Notify your pediatrician if your infant has consumed formula from these batches, even if no symptoms appear.

ByHeart has assured full refunds and stated that it is cooperating with federal agencies to prevent recurrence.

States Reporting Infant Botulism Cases

As of November 9, 2025, confirmed cases have been reported in Arizona, California, Illinois, New York, Pennsylvania, Texas, Florida, Ohio, Colorado, and Washington.

Health departments in these states have issued parallel alerts urging parents to immediately verify the contents of their formula containers. Hospitals have been instructed to report any new infant botulism diagnoses to the CDC for tracking.

While the majority of affected infants have been discharged or are in stable condition, the cluster underscores the importance of maintaining stringent safety standards in formula manufacturing. This sector serves the nation’s most vulnerable population.

Symptoms Parents Should Watch For

Even if your baby appears well, vigilance is critical. Pediatric experts recommend monitoring for:

Reduced sucking strength or difficulty swallowing
Constipation lasting more than three days
Weak cry or diminished facial expression
Noticeable fatigue or drooping eyelids
Sudden limpness in arms or legs

If any of these occur, seek immediate medical care. Hospitals can administer Botulism Immune Globulin Intravenous (BIG-IV), a specialized antitoxin that neutralizes the circulating toxin.

The earlier treatment begins, the faster the recovery and the lower the risk of complications. Parents are encouraged to mention formula use during medical evaluations to help clinicians quickly identify potential links.

What To Do If You Used the Recalled Formula

If your baby consumed the recalled lots but shows no symptoms, stay calm—botulism is rare even when exposure occurs. Here’s what experts recommend:

Stop use immediately and discard the remaining product.
Inform your pediatrician so they can note possible exposure in medical records.
Observe for signs of weakness, constipation, or reduced feeding for up to 30 days.
Keep receipts or product photos if you plan to request reimbursement.
Avoid panic-driven formula switching; consult your pediatrician before changing brands to ensure nutritional continuity.

ByHeart has set up a 24-hour recall hotline and dedicated web portal to answer questions and process claims.

ByHeart’s Response and Recall Statement

In a transparent move, ByHeart publicly addressed parents via video and social-media channels within 24 hours of the FDA announcement. Co-founder and CEO Ron Belldegrun expressed regret and reaffirmed the company’s commitment to safety:

“We built ByHeart on the promise of trust and uncompromising quality. While this voluntary recall affects only two lots, even one risk to a child is one too many.”

The company also stated that it had halted production at the affected facility and initiated a third-party microbial audit to ensure that no contamination risk remains.

ByHeart’s formula, known for being non-GMO, pesticide-free, and made with grass-fed milk, has earned praise from parents seeking cleaner alternatives. This recall represents a severe test of the company’s reputation, but its proactive transparency may help maintain consumer confidence in the long run.

How the Recall Impacts Other Infant Formulas

Although only ByHeart products are directly implicated, the recall renews scrutiny across the entire infant-nutrition industry.

Competing brands, including Similac, Enfamil, and Gerber, have issued statements reaffirming their compliance with FDA sanitation protocols. However, supply chains remain fragile; even a partial recall can lead to temporary shortages and consumer anxiety.

Experts warn against hoarding or switching abruptly without consulting a doctor. Each infant formula has a distinct nutritional composition—sudden changes can cause digestive issues, allergies, or nutrient imbalances.

This event underscores the need to continue modernizing oversight of formula production, including real-time microbial monitoring and more stringent reporting requirements.

Keeping Your Baby Safe: Expert Advice & Next Steps

Health professionals emphasize three key takeaways for parents navigating this crisis:

Stay Informed Through Official Channels. Use the FDA and CDC websites for verified updates. Avoid social media speculation that could spread misinformation.
Register for Formula Alerts. Both agencies allow consumers to sign up for recall notifications by email or text—an essential tool for families with infants under 1 year old.
Advocate for Transparency. Support legislative and regulatory efforts to promote open data sharing on contamination testing in the baby formula industry.

Additionally, pediatric dietitians encourage parents to diversify infant nutrition once appropriate—introducing solids gradually after six months to reduce reliance on formula.

For those seeking immediate alternatives, healthcare providers can recommend FDA-approved brands suited to your baby’s age and dietary needs.

The Wider Conversation on Infant Formula Safety

This recall reignites debate over how infant formula is regulated in the United States. After the 2022 Abbott Nutrition shutdown led to widespread shortages, Congress directed the FDA to strengthen its inspection network and improve early-warning mechanisms.

ByHeart’s case suggests that while progress has been made, gaps remain—particularly in microbial testing at dry-powder facilities. Public health advocates are now calling for mandatory weekly environmental swabs and independent audits of formula plants.

Consumer trust in infant-nutrition companies depends on transparency. Parents must feel confident that every spoonful they feed their baby meets the highest possible safety standards.

A Message to Parents

For millions of families, infant formula is more than just food—it’s a lifeline. The emotional toll of hearing about contamination in such a vital product cannot be understated.

While the current outbreak is deeply concerning, it also highlights the importance of rapid response and cooperation between manufacturers and regulators to prevent greater harm. Every hospitalized baby so far has received treatment, and medical experts are optimistic about full recovery.

Parents who remain uncertain about feeding choices should not hesitate to reach out to pediatricians or local health departments for guidance. In crises like this, knowledge truly is power—and it can save lives.

Conclusion: Learning from the ByHeart Recall

The ByHeart formula recall serves as both a cautionary tale and a reminder of progress. Swift detection, transparent communication, and decisive action have likely prevented more serious outcomes.

Yet the incident underscores the fragile trust between consumers and the companies that nourish their children. In the months ahead, the FDA’s investigation will reveal how the contamination occurred and what reforms can prevent future outbreaks.

Until then, the best protection remains vigilance: check every can, follow official updates, and place your child’s safety above convenience or brand loyalty.

For ByHeart, rebuilding trust will take time—but its decision to act quickly, openly, and compassionately may prove to be its most decisive step yet toward redemption.

For more information : ByHeart downplays its involvement in Child Botulism Outbreak

Alzheimer’s New Study: Walking 3,000 Steps Could Slow Alzheimer’s